|
[1]
|
Zhou MG, Wang HD, Zeng XY, Yin P, Zhu J, Chen WQ, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019;394(10204):1145 − 58. http://dx.doi.org/10.1016/S0140-6736(19)30427-1CrossRef
|
|
[2]
|
Chinese Center for Disease Control and Prevention, The National Center for Chronic and Noncommunicable Disease Control and Prevention. Report on chronic disease risk factor surveillance in China 2018. Beijing: People’s Medical Publishing House. 2021. http://product.dangdang.com/29356233.html. (In Chinese)http://product.dangdang.com/29356233.html |
|
[3]
|
Yin P, Qi JL, Liu YN, Liu JM, You JL, Wang LJ, et al. Incidence, prevalence, and mortality of four major chronic non-communicable diseases — China, 1990-2017. China CDC Wkly 2019;1(3):32 − 7. http://dx.doi.org/10.46234/ccdcw2019.012CrossRef
|
|
[4]
|
Yang GH, Wang Y, Zeng YX, Gao GF, Liang XF, Zhou MG, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013;381(9882):1987 − 2015. http://dx.doi.org/10.1016/S0140-6736(13)61097-1CrossRef
|
|
[5]
|
Jia LF, Du YF, Chu L, Zhang ZJ, Li FY, Lyu DY, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 2020;5(12):e661 − 71. http://dx.doi.org/10.1016/S2468-2667(20)30185-7CrossRef
|
|
[6]
|
Prince MJ, Wu F, Guo YF, Robledo LMG, O’Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015;385(9967):549 − 62. http://dx.doi.org/10.1016/S0140-6736(14)61347-7CrossRef
|
|
[7]
|
Wu DZ, Wong P, Guo C, Tam LS, Gu JR. Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017. BMC Med 2021;19(1):34. http://dx.doi.org/10.1186/s12916-021-01905-wCrossRef
|
|
[8]
|
Yao Y, Yin PB, Liu XY. Falls prevention in China: time for action. Lancet Public Health 2021;6(12):e875 − 6. http://dx.doi.org/10.1016/S2468-2667(21)00251-6CrossRef
|
|
[9]
|
Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China. Eur J Clin Nutr 2017;71(1):149 − 50. http://dx.doi.org/10.1038/ejcn.2016.171CrossRef
|
|
[10]
|
He L, Zhang YF, Shen XC, Sun Y, Zhao Y. Prevalence trends of multimorbidity among residents in mainland China: a meta-analysis. Chin Gen Pract 2023;26(29):3599 − 607. http://dx.doi.org/10.12114/j.issn.1007-9572.2023.0217 (In Chinese). CrossRef
|
|
[11]
|
Zheng XY, Guo C. Strengthening systematic research on aging: reflections from an omics perspective. China CDC Wkly 2022;4(39):875 − 8. http://dx.doi.org/10.46234/ccdcw2022.181CrossRef
|
|
[12]
|
Zheng XY, Luo YN, Su BB, He P, Guo C, Tian YH, et al. Developmental gerontology and active population aging in China. China CDC Wkly 2023;5(8):184 − 7. http://dx.doi.org/10.46234/ccdcw2023.033CrossRef
|